Dr. Huijun Ring received her PhD in molecular biology and genetics from Cornell University and completed her post-doctoral medical genetics training at Stanford University School of Medicine. She is a clinical molecular geneticist and board-certified by the American Board of Medical Genetics.

Dr. Ring is an experienced biotech entrepreneur and executive. Previously she worked at Incyte Pharmaceuticals and DNA Direct in Silicon Valley. She was the founder and CEO of iDNA Inc, a precision medicine company. iDNA Inc. was named as one of the fastest growing technology companies in China by Deloitte and was acquired by a public company. She has also cofounded and advised several biotech startups in Silicon Valley and mentored many first-time entrepreneurs.

Currently, Dr Ring is an Adjunct Professor at Department of Medicine, Stanford University. She teaches “Future of Precision Health”, “Foundamentals for Engineering Biology Lab“ and “Science and History of Traditional Chinese Medicine” at Stanford. She is involved in mentoring Stanford Graduate School of Business students, Knight-Hennessy Scholars, and junior women faculty in science and medicine through the Stanford University Faculty Development Office. Dr. Ring serves as the faculty advisor/Secondary PI for the 2023 Stanford iGEM team and is also on the judging committee at the iGEM International Final, which is the world's largest synthetic biology competition.